Jaiswal A K
Department of Pharmacology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas, 77030, USA.
Arch Biochem Biophys. 2000 Mar 1;375(1):62-8. doi: 10.1006/abbi.1999.1650.
Quinone oxidoreductases are flavoproteins that catalyze two-electron reduction and detoxification of quinones. This leads to the protection of cells against toxicity, mutagenicity, and cancer due to exposure to environmental and synthetic quinones and its precursors. Two cytosolic forms of quinone oxidoreductases [NAD(P)H:quinone oxidoreductase 1 (NQO1) and NRH:quinone oxidoreductase 2 (NQO2)] were previously identified, purified, and cloned. A role of cytosolic NQO1 in protection of cells from oxidative stress, cytotoxicity, and mutagenicity of quinones was established. Currently, we have characterized and partially purified the NQO activity from rat liver microsomes. This activity was designated as microsomal NQO (mNQO). The mNQO activity showed significantly higher affinity for NADH than NADPH as electron donors and catalyzed reduction of 2,6-dichlorophenolindophenol and menadione. The mNQO activity was insensitive to dicoumarol, a potent inhibitor of cytosolic NQO1. Western analysis of microsomal proteins revealed 29- and 18-kDa bands that cross-reacted with polyclonal antibodies raised against cytosolic NQO1. The mNQO activity was partially purified by solubilization of microsomes with detergent Chaps, ammonium sulfate fractionation, and DEAE-Sephacel column chromatography. The microsomal mNQO proteins are expected to provide additional protection after cytosolic NQOs against quinone toxicity and mutagenicity.
醌氧化还原酶是一种黄素蛋白,可催化醌的双电子还原和解毒。这导致细胞免受因接触环境和合成醌及其前体而产生的毒性、致突变性和癌症的侵害。先前已鉴定、纯化并克隆了两种胞质形式的醌氧化还原酶[NAD(P)H:醌氧化还原酶1 (NQO1)和NRH:醌氧化还原酶2 (NQO2)]。胞质NQO1在保护细胞免受醌的氧化应激、细胞毒性和致突变性方面的作用已得到证实。目前,我们已对大鼠肝微粒体中的NQO活性进行了表征并部分纯化。该活性被命名为微粒体NQO (mNQO)。作为电子供体,mNQO活性对NADH的亲和力明显高于对NADPH的亲和力,并催化2,6-二氯酚靛酚和甲萘醌的还原。mNQO活性对双香豆素不敏感,双香豆素是胞质NQO1的有效抑制剂。对微粒体蛋白的Western分析显示,有两条分别为29 kDa和18 kDa的条带与针对胞质NQO1产生的多克隆抗体发生交叉反应。通过用去污剂Chaps溶解微粒体、硫酸铵分级分离和DEAE-葡聚糖凝胶柱色谱法对mNQO活性进行了部分纯化。预计微粒体mNQO蛋白在胞质NQO之后可提供额外的保护,防止醌的毒性和致突变性。